Axitan expands distribution into Latin America FORC3® and NMAN® now on sale in Chile
Comer, Georgia: Axitan Inc, the leading biotech company focused on the development, manufacture and sale of endolysin enzyme products to replace antibiotics in the animal protein industry, is pleased to announce that FORC3®and NMAN® are now available in Chile.
Al Zimmerman, CEO of Axitan, commented:
“Making Axitan’s products available in Chile forms part of our strategy to grow sales across Latin America. To that end, we applaud the governing bodies progress in Chile to reduce the use of antibiotics in the animal protein industry – they are at the forefront of policy change in the region. The successful registrations of our products in Chile now allow local producers to more confidently manage their flock health and performance programs antibiotic-free.”
Both FORC3® and NMAN® incorporate ground-breaking Axitan technologies to improve livability, performance and uniformity in poultry flocks. FORC3® by addressing the causative agent of necrotic enteritis, Clostridium perfringens, that impacts performance long before NE clinically surfaces; NMAN® by improving hydration and nutrition in newly born chicks.
Axel Cruz Farga, General Manager at Comercializadora Veterprime Axel Cruz E.I.R.L., the company appointed by Axitan to manage the product registrations and ongoing sales in Chile, said:
“Making Axitan’s products available in Chile forms part of our strategy to grow sales across Latin America. To that end, we applaud the governing bodies progress in Chile to reduce the use of antibiotics in the animal protein industry – they are at the forefront of policy change in the region. The successful registrations of our products in Chile now allow local producers to more confidently manage their flock health and performance programs antibiotic-free.”
To learn more about Axitan and its products, visit www.axitan.com.
Comercializadora Veterprime Axel Cruz E.I.R.L can be contacted at https://www.linkedin.com/company/veterprime
About Axitan
Axitan is the leading biotech company focused on the development, manufacture and sale of novel endolysins to target and neutralize pathogens impacting animal production & food safety. The endolysins form the core of Axitan’s formulated, performance improving, feed additive products. Through its technology platform, Axitan is building the next generation of feed additives for targeting tough pathogens, without antibiotics. Its mission is to facilitate the full and safe removal of antibiotics in animal production through endolysin-based solutions. Axitan’s operations are located in the US and UK. For further information on the Company and its products, please visit www.axitan.com.